Alpharmagen LLC

États‑Unis d’Amérique

 
Quantité totale PI 5
Rang # Quantité totale PI 309 571
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 656 829

Brevets

Marques

1 0
0 0
4 0
0
 
Dernier brevet 2017 - Polymorphs of a phosphate salt o...
Premier brevet 2008 - 4-substituted quinuclidine deriv...

Derniers inventions, produits et services

2017 Invention Polymorphs of a phosphate salt of quinuclidin-4-ylmethyl 4-methyl-1h-indole-3-carboxylate and use...
2016 Invention Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereo...
2015 Invention Quinuclidine compounds for modulating alpha7 -nicotinic acetylcholine receptor activity. Provided...
Invention Quinuclidines for modulating alpha 7 activity. Provided are substituted quinuclidine compounds, p...
2013 Invention Α7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof. Th...
2010 Invention Α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof. T...
2008 Invention 4-substituted quinuclidine derivatives, methods of production, and pharmaceutical uses thereof. T...
Invention 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof. The p...